Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 clinical trials that are recruiting, at sites in 2 countries (most in United States (9), Canada (1)). By phase: Phase 2 (6), Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 2Countries
Newest Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 clinical trials
All recruiting trials (9)
-
Adding chemotherapy or chemo-immunotherapy to standard salvage surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy alone or chemotherapy plus the immunotherapy cemiplimab before salvage surgery helps people with PD-L1–positive recurrent or persistent head and neck squamous cell carcinoma.
-
Lowering neck radiation dose in HPV-related oropharyngeal cancer
This trial tests whether giving a lower dose of radiation to the elective neck lymph nodes while treating the primary tumor can maintain good cancer control with fewer side effects in adults with HPV-related oropharyngeal cancer.
-
Comparing two imaging techniques for assessing blood vessel effects in head and neck cancer patients receiving radiation therapy
This study is testing if a new type of imaging can better spot blood vessel problems in head and neck cancer patients getting radiation therapy compared to the usual imaging method.
-
Adding BMX-001, a drug that protects normal tissue from radiation damage, to standard chemoradiation for head and neck cancer
This trial tests whether giving BMX-001 along with usual mouth-care reduces severe mouth sores in people getting cisplatin-based chemoradiation for HPV-related and other head and neck cancers.
-
Lower dose radiation therapy guided by blood tests for HPV-related throat cancer
This study is testing if using blood tests to guide lower doses of radiation therapy can help people with HPV-related throat cancer do better than the usual treatment.
-
Using blood tests to tailor radiation therapy for HPV-positive throat cancer
This study is testing if blood tests can help doctors decide how much radiation therapy patients with HPV-positive throat cancer really need, aiming to reduce side effects while still effectively treating the cancer.
-
Combining Ipatasertib with Chemotherapy and Radiation for Head and Neck Cancer
This study is testing if adding a new drug called ipatasertib to chemotherapy and radiation can help people with advanced head and neck cancer feel better and improve their treatment results.
-
Tailored treatment for HPV-positive oropharyngeal cancer using blood tests
This study is testing a new way to tailor treatment for people with HPV-related throat cancer by using blood tests to see if adjusting their radiation and chemotherapy can improve their outcomes.
-
Studying how well head and neck cancer patients follow swallowing exercises after radiation
This study looks at how well people with head and neck cancer stick to their swallowing exercises after radiation treatment and what factors might help or hinder them.
Related topics
Quick answers
How many Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (9 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.